cagrisema semaglutide cagrilintide combination trial ECO 2026 Three new phase 3 REIMAGINE

The groups that received the riboflavin-fortified salt had lower rates of esophageal cancer.[ref] Inflammatory Bowel Disease (IBD): In patients with Crohns disease, riboflavin (100mg/day) decreased inflammatory markers significantly in three weeks.[ref] Related article: IBD and Genetic Connections Inflammation: A randomized, placebo-controlled trial of supplemental riboflavin found that it reduced inflammation based on a lower CRP level.[ref] Related article : Inflammation and chronic disease Gut microbiome interactions with riboflavin: Certain gut microbes can produce riboflavin, part of which is then absorbed into the body

Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl2 expression after focal cerebral ischemia

Retatrutide Benefits (and the Fine Print) What do we know at this point about the potential benefits of retatrutide

Front Physiol 2019;10:914